Page last updated: 2024-09-04

docetaxel anhydrous and meglumine

docetaxel anhydrous has been researched along with meglumine in 2 studies

Compound Research Comparison

Studies (docetaxel anhydrous)	Trials (docetaxel anhydrous)	Recent Studies (post-2010) (docetaxel anhydrous)	Studies (meglumine)	Trials (meglumine)	Recent Studies (post-2010) (meglumine)
12,110	3,216	6,920	4,168	413	1,399

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Brunton, T; Evans, A; Henderson, SA; Jordan, LB; Muhammad Gowdh, N; Purdie, CA; Thompson, AM; Vinnicombe, S	1
Buckley, DL; Dall, BJ; Dodwell, D; Farrow, IM; Georgiou, L; Hanby, AM; Hughes, TA; Perren, TJ; Sharma, N; Stevens, W; Wilson, DJ; Windel, LM	1

Other Studies

2 other study(ies) available for docetaxel anhydrous and meglumine

Article	Year
Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy. The British journal of radiology, 2018, Volume: 91, Issue:1087 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Tumor Burden	2018
Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response. The British journal of radiology, 2021, Jul-01, Volume: 94, Issue:1123 Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Trastuzumab; Tumor Burden	2021

Article

Year

Breast cancer: influence of tumour volume estimation method at MRI on prediction of pathological response to neoadjuvant chemotherapy.

The British journal of radiology, 2018, Volume: 91, Issue:1087

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Fluorouracil; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Taxoids; Trastuzumab; Treatment Outcome; Tumor Burden

2018

Breast tumour volume and blood flow measured by MRI after one cycle of epirubicin and cyclophosphamide-based neoadjuvant chemotherapy as predictors of pathological response.

The British journal of radiology, 2021, Jul-01, Volume: 94, Issue:1123

Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Chemotherapy, Adjuvant; Contrast Media; Cyclophosphamide; Docetaxel; Epirubicin; Female; Humans; Magnetic Resonance Imaging; Meglumine; Middle Aged; Neoadjuvant Therapy; Organometallic Compounds; Predictive Value of Tests; Prospective Studies; Trastuzumab; Tumor Burden

2021